alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Clinical trials

Clinical trials

Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.

If you are thinking about joining a trial

A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.

Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.

Clear filters Download all 7,816 as CSV

"Open to new participants" means the registry status is RECRUITING or NOT_YET_RECRUITING — 1,523 of the 7,816 records. That is what the sponsor last told the registry, which can be months out of date.
Location is by country. This pull of the registry records the countries a study runs in, not its individual sites, so we cannot filter by US state or city — and we are not going to guess one. To find the nearest site, open a trial's record below: the official page lists every location with its contact details.

Showing 2,801–2,825 of 7,816 matching trials · page 113 of 313, 25 per page.

Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.

Registered Alzheimer's clinical trials. Every ID links to its official ClinicalTrials.gov record.
Trial Phase Status Enrolled Sponsor Last updated
Assessing a Novel Virtual Environment That Assists With Activities of Daily Living
NCT05418296
A novel digital health device
Runs in: United States · 2 sites 		NA
other		 COMPLETED 38 mandy
INDUSTRY		 2025-02-10
The Ketogenic Diet in the Treatment of Behavioral Variant Frontotemporal Dementia
NCT06761729
Ketogenic diet 		NA
other		 NOT_YET_RECRUITING 3 Xuanwu Hospital, Beijing
OTHER		 2025-02-10
Forest Bathing Intervention for Persons Living with Dementia and Family Carers
NCT06813196
Forest Bathing; Art activity
Runs in: Hong Kong · 1 site 		NA
other		 COMPLETED 107 The University of Hong Kong
OTHER		 2025-02-10
A Phase 1 Study of VG-3927 in Healthy Adults and Patients With Alzheimer's Disease
NCT06343636
VG-3927; Placebo; VG-3927
Runs in: Australia; United States · 3 sites 		PHASE1
other		 COMPLETED 115 Vigil Neuroscience, Inc.
INDUSTRY		 2025-02-07
A Study Evaluating the Potential of BMS-984923 to Alter the Systemic Exposure of Three Orally Administered Probe Substrates
NCT06632990
BMS-984923; Midazolam; Caffeine; dextromethorphan
Runs in: United States · 1 site 		PHASE1
other		 ACTIVE_NOT_RECRUITING 36 Allyx Therapeutics
INDUSTRY		 2025-02-07
Efficacy of Music Therapy and Digital Music Rehabilitation in Dementia
NCT05520268
Conventional music therapy (CMT); Digital music rehabilitation (DMR)
Runs in: Finland · 1 site 		NA
other		 RECRUITING 192 University of Helsinki
OTHER		 2025-02-06
[18F]-MFBG Versus [123I]-MIBG and [18F]-PE2I in PD vs. MSA and DLB vs. AD
NCT06120049
[18F]-MFBG PET CT; [18F]-FE-PE2I PET CT or PET MRI; [123I]-MIBG SPE...
Runs in: Belgium · 2 sites 		PHASE2|PHASE3
other		 RECRUITING 113 prof. dr. Koen Van Laere
OTHER		 2025-02-06
Home-Based Exercise in Primary Progressive Aphasia (HEPPA)
NCT06181500
Home-based multicomponent exercise intervention program
Runs in: Canada · 2 sites 		NA
other		 COMPLETED 13 Montreal Heart Institute
OTHER		 2025-02-06
Effect of Consuming a Mixture of Extracts and DHA on the Mild Cognitive Impairment
NCT06254040
Placebo; mixture of extracts and DHA
Runs in: Spain · 1 site 		NA
other		 COMPLETED 110 Biosearch S.A.
INDUSTRY		 2025-02-06
Impact of NANO-PSO on Cognition in Older Adults with Mild to Moderate Cognitive Impairment
NCT06520878
NANO-PSO (pomegranate seed oil); Placebo
Runs in: Mexico · 1 site 		PHASE2
other		 RECRUITING 60 Distribuidora Biolife SA de CV
INDUSTRY		 2025-02-06
REMINDer - A Digital Environmental Enrichment Intervention
NCT06530277
REMINDer (A digital environmental enrichment intervention)
Runs in: Germany · 1 site 		NA
other		 COMPLETED 58 German Center for Neurodegenerative Diseases (DZNE)
OTHER		 2025-02-06
Environmental and Sensory Intervention for Nursing Home Residents With Dementia Who Exhibit Persistent Vocalizations
NCT06568107
Environmental And Sensory Experience (EASE) intervention
Runs in: United States · 1 site 		NA
other		 RECRUITING 32 Drexel University
OTHER		 2025-02-06
Identification of Patients With a High Probability of Meeting Eligibility Criteria for an Alzheimer's Disease Clinical Trial (APHELEIA)
NCT05364307
Prescreener database
Runs in: Canada; United States · 19 sites 		NA
other		 COMPLETED 1,555 Global Alzheimer's Platform Foundation
OTHER		 2025-02-05
Outreach-ER: A Dementia Care Intervention Program
NCT05451693
Outreach-ER
Runs in: United States · 2 sites 		NA
other		 TERMINATED 8 HealthPartners Institute
OTHER		 2025-02-05
STAR Caregivers - Virtual Training and Follow-up
NCT04271046
STAR-C-VTF; Control
Runs in: United States · 1 site 		NA
other		 COMPLETED 67 Kaiser Permanente
OTHER		 2025-02-04
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia: A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation
NCT06424236
Gantenerumab
Runs in: Australia; France; Puerto Rico; Spain; United Kingdom; Un... · 17 sites 		PHASE2|PHASE3
anti-amyloid-antibody		 TERMINATED 73 Washington University School of Medicine
OTHER		 2025-02-04
Genetics and Environment iNtersection In the ALS-FTD Spectrum: an Italian Twins Cohort studY With a Multi-Omics Approach
NCT06595212
multiomic profile to assess genetic and environmental risk factiors
Runs in: Italy · 3 sites 		NA
other		 RECRUITING 45 Azienda Ospedaliero-Universitaria di Modena
OTHER		 2025-02-04
A Phase II Study to Assess the Safety, Tolerability and Efficacy of Xanamem™ in Subjects With Mild Dementia Due to AD (XanADu)
NCT02727699
Xanamem™; Placebo (for Xanamem™)
Runs in: Australia; United Kingdom; United States · 25 sites 		PHASE2
other		 COMPLETED 185 Actinogen Medical
INDUSTRY		 2025-02-03
Long-term Safety of Tafamidis in Subjects With Transthyretin Cardiomyopathy
NCT02791230
Tafamidis
Runs in: Argentina; Australia; Belgium; Brazil; Canada; Czechia; F... · 80 sites 		PHASE3
other		 COMPLETED 1,733 Pfizer
INDUSTRY		 2025-02-03
Low-Dose Lithium for the Treatment of Behavioral Symptoms in Frontotemporal Dementia
NCT02862210
Lithium Carbonate; Placebo
Runs in: United States · 1 site 		PHASE2
other		 COMPLETED 17 Columbia University
OTHER		 2025-02-03
Escitalopram for Agitation in Alzheimer's Disease
NCT03108846
Escitalopram; Placebo
Runs in: Canada; United States · 29 sites 		PHASE3
other		 ACTIVE_NOT_RECRUITING 187 JHSPH Center for Clinical Trials
OTHER		 2025-01-31
A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease
NCT05328115
ALZ-101; Placebo
Runs in: Finland · 1 site 		PHASE1
other		 COMPLETED 33 Alzinova AB
INDUSTRY		 2025-01-31
Implementation of MIND at Home Into Primary Care for People Living With Dementia
NCT05406921
MIND at Home
Runs in: United States · 2 sites 		NA
other		 COMPLETED 410 American Medical Group Association
OTHER		 2025-01-31
Pre-Pilot: Problem Adaptation THerapy in Caregivers
NCT05567120
PATH-Care
Runs in: United States · 1 site 		NA
other		 WITHDRAWN 0 Weill Medical College of Cornell University
OTHER		 2025-01-31
D-CARE - The Dementia Care Study: A Pragmatic Clinical Trial of Health System-Based Versus Community-Based Dementia Care
NCT03786471
Health System-based Dementia Care; Community-based Dementia Care; U...
Runs in: United States · 4 sites 		NA
other		 COMPLETED 2,176 University of California, Los Angeles
OTHER		 2025-01-30

This table is wider than a phone screen — swipe it sideways to see the rest.

Where these trials come from

Registry
ClinicalTrials.gov, pulled through their public API (v2)
Trials in the file
7,816
Source file
trials.csv (3.8 MB, 7816 rows)
Basis
Measured These are registry records as submitted by each study's sponsor.

What could make this misleading

Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.

Always check the official record before acting on anything here. This is a summary, not medical advice.

Related evidence Treatments → What the drugs that finished their trials actually achieved.

From the research library

The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.

Clinical trials

All 162 studies on Clinical trials →